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Abstract
Ablative fractionated carbon dioxide (fCO2) laser may be a useful tool to improve
noticeable scars after skin cancer surgery. Therefore we evaluated 40 patients who
have been treated with fCO2 laser for facial scars after skin cancer surgery. This ret-
rospective study is based on blinded evaluation of pre- and postoperative photo-
graphs. Patients (n = 40), laypersons (n = 5) and experts (n = 5) evaluated the
esthetics and the Vancouver scar scale as primary endpoints. Secondary endpoints
included patient satisfaction and treatment safety. Patients, laypersons and experts
consistently assessed a significant improvement of scar quality and appearance after
fCO2 laser treatment, which was paralleled by high patient satisfaction. In conclusion,
ablative fCO2 laser is effective in improving noticeable postsurgical scars. Patients
are highly satisfied with post-laser results.
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1 | INTRODUCTION
Skin cancer has become the most common neoplasia in humans. In
the United States, approximately five million skin cancers are surgi-
cally removed each year. The face is by far the most concerning loca-
tion for skin cancer. Despite optimal surgical technique, postoperative
scars may remain noticeable or unsightly.
fCO2 laser therapy has emerged as an effective tool to improve
disturbing skin scars and is increasingly used to treat unsightly scars
post-skin cancer surgery. Thus it helps improve psychological impair-
ment and raise patients' self-esteem.1
Several scientific studies have proven that fractional ablative
and non-ablative laser systems achieve a constant functional and
cosmetic improvement of scars.2-9 These lasers work according to
the principle of fractional photothermolysis and lead to dermal
collagen remodeling and neocollagenesis.10 fCO2 can be utilized ear-
lier postoperatively than conventional ablative CO2 laser, as well as
having a shorter postprocedural recovery time.2,5 We conducted this
retrospective study on 40 consecutive patients, in order to evaluate
the results of our fCO2 laser treatment for facial scars after skin
cancer surgery.
2 | PATIENTS AND METHODS
The surgical team of the Department of Dermatology, University Hos-
pital of Zurich, offers skin cancer surgery to approximately 2500
patients annually. In the period of 2015–2019, 47 patients with
esthetically disturbing postoperative facial scars were treated with a
fCO2 laser. All of these patients were traced and contacted for this
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study. 40/47 agreed to participate in a retrospective analysis of their
treatment outcome.
2.1 | Ethics statement
This study meets the requirements of the 1975 Declaration of
Helsinki and has been authorized by the responsible ethics com-
mittee (project ID: 2018-01563). All patients have given their
written informed consent to participate in this study. The patients
also consented to the anonymized use of the photographic
material.
2.2 | fCO2 laser treatment
We used a fractionated carbon dioxide laser (eCO2; Lutronic Co,
Goyang, Korea). Local anesthesia consisted of a lidocaine 23% -
tetracain 7% cream. All lesions were treated with a pulse energy of
40–60 mJ in the static mode; two passes were delivered using a
120-density tip (coverage 10%). Post-intervention, patients were
instructed to apply a skin-soothing moisturizer several times daily for
5 days. The authors advised the patients to ensure sun protection
with sunscreen (SPF 50+).
2.3 | Photo documentation
All patients had standard studio photo documentation, which was
conducted frontal, from the side and oblique (45%) perspective, using
the same distance and illumination.
2.4 | Assessment
Patients (n = 40), laypersons (n = 5), and experts (n = 5) assessed the
preoperative and postoperative photographs as follows:
The patients rated the esthetics of their own scar, before and
3 months after the laser treatment, on a scale from 1 (esthetically
inacceptable) - 10 (no longer recognizable as a scar). First, they evalu-
ated the result from their memory. Then they viewed and rated their
photographs before and 3 months after laser treatment. In an addi-
tional step they applied the Vancouver scar scale (VSS) to score the
scar before and 3 months after laser treatment. Subjective rating
encompassed the effect on self-confidence, therapeutic burden, pain,
undesirable effects, time spent, and overall satisfaction, using a
numeric scale from 1 (disappointed) to 5 (happy).
Pre- and postoperative photographs of each patient were
mounted side by side at random and presented to the blinded raters.
Five laypersons (employees of the cleaning and hygiene service of the
University Hospital Zurich) and five professionals (board certified der-
matologists) evaluated the scars on a scale from 1 (esthetically unac-
ceptable) to 10 (no longer recognizable as a scar).
2.5 | Statistics
Of the 47 patients who underwent fCO2 laser treatment at the Uni-
versity Hospital of Zurich in 2015–2019, 40 patients returned the
declaration of consent, hence they could be included in the study. To
our knowledge, this represents one of the largest sample sizes known
in the literature, regarding the subject of fCO2 laser for scar
treatment.
The mean scores for the ratings of the patients, the five layper-
sons and the five experts were calculated for each photograph before
and after therapy and compared with an exact Wilcoxon signed rank
test. The overall scores of the VSS were also compared with an exact
Wilcoxon signed rank test. The individual parameters of the VSS
before and after therapy were compared with an exact sign test. A p-
value of <0.05 has been defined as significant.11 All analyses were
performed in the R programming language (version 3.6.2) (R Core
Team, 2019).12-15
3 | RESULTS
A total of 40 patients consented to participate and were enrolled in
this retrospective study. Baseline characteristics and the treatment
protocols are given in Table 1.
Based on their memory, patients rated that the scars significantly
improved after fCO2 laser treatment (median 3.5 pre vs. 7.0 post,
TABLE 1 Patient characteristics




Mean age (year) 62.7 (33–85)











Age of the scar at first laser treatment (months),
Mean (range)
5.7 (1–24)
No. of laser treatment sessions, Mean (range) 2.2 (1–6)
Interval between laser treatment sessions (weeks),
Mean (range)
7.3 (4–12)
Follow-up time (months), Mean (range) 14.7 (3–26)
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p < 0.001). After viewing the photographs, rating was even more
favorable (median 3.0 pre vs. 7.0 post, p < 0.001) (shown in Figure 1).
However, the difference to the rating based on memory remained
non-significant (p = 0.71).
Ratings with the VSS are given in Table 2. Median sum score was
significantly improved (6.0 pre vs. 4.0 post, p = <0.001).
The median patient satisfaction with the overall laser treatment
was 4.5 (IQR: 3.8-5.0). Overall the laser treatment was very well toler-
ated. Side effects were mild to moderate pain during the treatment
and mild to moderate post-treatment erythema and edema (CTCAE
grade 1-2). There were no other adverse events such as dys-
pigmentation or worsening of the scar.
Based on blinded photographic scar assessment, both laypersons
and experts consistently distinguished the baseline and the post-
interventional photograph in all patients. Furthermore, both groups
rated that the scars post-fCO2 laser treatment significantly improved
(p < 0.001). Experts rated the effect higher by 0.5 points (p = 0.017)
(shown in Figure 2).
4 | DISCUSSION/CONCLUSION
This retrospective study suggests that fCO2 laser effectively
improves disturbing facial scars post-skin cancer surgery. At a
first attempt the patients remembered their scars to have sig-
nificantly improved after the laser intervention. Blinded
patients, laypersons and experts rated the post-interventional
photographic aspect significantly higher, and patients rated the
effect on the photos even more positive than based on their
memory (examples shown in Figures 3, 4, 5, and 6 and in
Figures S1 and S2).
The assessment of the scars on the Vancouver scar scale also
showed significant improvements of the overall scores, as well as of
all the individual parameters after laser therapy. The parameters “pli-
ability” and “height” of the VSS improved the most, which did not
surprise the authors, as the fCO2 laser most notably leads to colla-
gen remodeling16 and is especially superior in the treatment of
hypertrophic scars.2 Compared to Choi et al17 our results not only
show an improvement of the parameter “pliability”, but also of the
parameters “height”, “pigmentation”, and “vascularization”. The
study of Sobanko et al showed a significant improvement in the
overall VSS and in 3 out of 4 of its individual parameters, but no sig-
nificant improvement of the parameter “pigmentation”.7 The study
of Lee et al9 showed similar results to ours, but in a substantially
smaller patient population.
The significant improvements of the esthetics of the facial scars
after fCO2 laser treatment are reflected in the very high patient satis-
faction and thus also lead to an improvement in patients' self-confi-
dence. Also, the side effects are usually mild and temporary such that
the burden of treatment is low. High subjective patient satisfaction in
connection with a fCO2 laser therapy has already been reported
in other studies, however, our study, in addition to the work of Lee
et. al, is the only one that has also objectified this through
questionnaires.9
In summary, even though the assessments by the three different
groups show some subtle differences, our results show a very coher-
ent overall picture. The fact that patients, laypersons and experts con-
sistently assessed a significant improvement of scar quality and
appearance after fCO2 laser treatment makes the study results
robust and represents definitely one of the biggest strengths of this
study. The sample size of 40 patients is also considered another
strength of this trial. Nearly all patients with a scar after skin cancer
surgery in the face who went for fCO2 laser treatment at the
Department of Dermatology USZ have been included in the study.
This allows to make robust inference from the sample to the overall
population. Other strengths of our study design include: blinding of
the layperson and experts to the pre- and post-treatment photo-
graphs, similar anatomic locations (centrofacial) as well as same eti-
ology (skin cancer surgery) of all scars and an extended follow-up of
averagely 14.7 months.
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before laser treatment
with looking at the photographs
after laser treatment
F IGURE 1 Comparison of the median esthetics scores, evaluated
by patients
TABLE 2 Comparison of the VSS before and after laser therapy, evaluated by the patients
VSS parameter Pre-laser treatment Post-laser treatment p-value
Pigmentation 1.0 (IQR: 1.0–2.0) 1.0 (IQR: 1.0–1.0) 0.004 (9 patients improved; 0 patients deteriorated)
Vascularity 1.0 (IQR: 0–2.0) 0.5 (IQR: 0.0–1.0) <0.001 (16 patients improved; 0 patients deteriorated)
Pliability 2.0 (IQR: 2.0–3.0) 1.0 (IQR: 1.0–2.2) <0.001 (21 patients improved; 0 patients deteriorated)
Height 1.0 (IQR: 1.0–2.0) 1.0 (IQR: 0.0–1.0) <0.001 (23 patients improved; 1 patient deteriorated)
Total VSS 6 (IQR: 5.0–7.0) 4 (IQR: 2.8–5.0) <0.001
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There are also some limitations to our study. First, although
objective measurement of scar appearance was done by the blinded
layperson and experts, the patients could not be blinded to the pre-
and post-treatment photographs. This knowledge could have biased
their subjective measurement of the scar esthetics. Second and even
more important, this retrospective study does not include a control
group. Since the whole scar was treated, the authors cannot make any
comparison how the scar would have developed without laser
treatment.
Next we plan a split-scar study, where one half of the scar
gets fCO2 laser treatment and the other half of the scar
remains untreated, like previously performed on skin grafts by
Datz E et al.18 Alternatively, a split-scar study where one half
of the scar population receives a fractional CO2 laser treat-
ment and the other half is treated with an ablative fractional
Er:YAG (erbium-doped yttrium aluminum garnet) laser or a nor-
mal ablative CO2 laser, would be conceivable. This study would
evaluate whether the fCO2 laser is really superior to other
lasers or if the lasers all entail similar effectiveness. A recently
published study showed a slight superiority of the fCO2 laser
over a long pulsed Nd:YAG (neodymium-doped yttrium alumi-
num garnet) laser in treatment of hypertrophic scars.19 How-
ever, this study had not been conducted in the format of a
split-scar study.
4 (IQR: 3.0 - 5.0)
5 (IQR: 3.0 - 5.0)

















F IGURE 2 Comparison of the median esthetics scores, evaluated
by the layperson and experts
F IGURE 3 Patient 1: pre-treatment photograph
F IGURE 4 Patient 1: post-treatment photograph
F IGURE 5 Patient 2: pre-treatment photograph
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5 | CONCLUSION
Disturbing facial scars from skin cancer surgery can be significantly
improved by fCO2 laser treatment. Particularly esthetics, pliability, and
height become significantly better. To confirm these findings, random-
ized controlled split scar studies are indispensable.
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